{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:10:01Z","timestamp":1779307801152,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019268","name":"Showa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euros.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:24:15Z","timestamp":1775755455000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of Nonpharmacological and Nonsurgical Intervention for Lower Urinary Tract Symptoms in Parkinson\u2019s Disease: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-5620","authenticated-orcid":false,"given":"Hiroyuki","family":"Ohtsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mifuka","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeya","family":"Kitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yoneoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.03.009_b0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.euros.2026.03.009_b0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson\u2019s disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","article-title":"Bladder and bowel dysfunction in Parkinson\u2019s disease","volume":"115","author":"Sakakibara","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.euros.2026.03.009_b0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2011.241075","article-title":"Urinary dysfunction in early and untreated Parkinson\u2019s disease","volume":"82","author":"Uchiyama","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.euros.2026.03.009_b0025","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/iju.12421","article-title":"Bladder function of patients with Parkinson\u2019s disease","volume":"21","author":"Sakakibara","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.euros.2026.03.009_b0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jogn.2016.04.008","article-title":"The experience of women who care for spouses with Parkinson\u2019s disease and lower urinary tract symptoms","volume":"45","author":"Moriarty","year":"2016","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.euros.2026.03.009_b0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000335078","article-title":"Sleep-wake disturbances in Parkinson\u2019s disease: current evidence regarding diagnostic and therapeutic decisions","volume":"67","author":"Bruin","year":"2012","journal-title":"Eur Neurol"},{"key":"10.1016\/j.euros.2026.03.009_b0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2015.11.055","article-title":"Influence of urinary urgency and other urinary disturbances on falls in Parkinson\u2019s disease","volume":"360","author":"Sakushima","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.euros.2026.03.009_b0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jech.44.3.246","article-title":"Handicaps associated with incontinence: implications for management","volume":"44","author":"McGrother","year":"1990","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.euros.2026.03.009_b0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18773\/austprescr.2022.031","article-title":"The anticholinergic burden: from research to practice","volume":"45","author":"Hilmer","year":"2022","journal-title":"Aust Prescr"},{"key":"10.1016\/j.euros.2026.03.009_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40266-019-00731-3","article-title":"Use of medications with anticholinergic properties and the long-term risk of hospitalization for falls and fractures in the EPIC-Norfolk longitudinal cohort study","volume":"37","author":"Tan","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.euros.2026.03.009_b0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.euros.2026.03.009_b0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium - theory, evidence and practice","volume":"81","author":"Dawson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.euros.2026.03.009_b0080","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bju.12649","article-title":"Phase III, randomised, double-blind, placebo-controlled study of the \u03b23-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder","volume":"113","author":"Yamaguchi","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.03.009_b0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","article-title":"Co-morbidity and polypharmacy in Parkinson\u2019s disease: insights from a large Scottish primary care database","volume":"17","author":"McLean","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.euros.2026.03.009_b0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.29.02.06.dc05-1781","article-title":"Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program","volume":"29","author":"Brown","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.euros.2026.03.009_b0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jama.1986.03380030074031","article-title":"Bladder training and related therapies for urinary incontinence in older people","volume":"256","author":"Hadley","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2026.03.009_b0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11934-013-0358-1","article-title":"Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training","volume":"14","author":"Burgio","year":"2013","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euros.2026.03.009_b0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1352458506070729","article-title":"Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis","volume":"13","author":"Centonze","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.euros.2026.03.009_b0110","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neurom.2022.04.034","article-title":"Transcutaneous tibial nerve stimulation in the management of overactive bladder: A scoping review","volume":"25","author":"Sayner","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/j.euros.2026.03.009_b0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ucl.2010.06.007","article-title":"Neuromodulation and the neurogenic bladder","volume":"37","author":"Burks","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euros.2026.03.009_b0120","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00192-010-1165-6","article-title":"Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women","volume":"21","author":"Schreiner","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euros.2026.03.009_b0125","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.03.009_b0130","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2026.03.009_b0135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2026.03.009_b0140","unstructured":"GDT GR. Hamilton (ON). Hamilton, Canada: McMaster University (developed by Evidence Prime); 2022, gradepro.org; 2022."},{"key":"10.1016\/j.euros.2026.03.009_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1545968311421614","article-title":"Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease","volume":"26","author":"Duncan","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.euros.2026.03.009_b0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/acm.2012.0774","article-title":"Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study","volume":"20","author":"Duncan","year":"2014","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.euros.2026.03.009_b0155","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: A pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0160","first-page":"E555","article-title":"Quality of Life and non-motor symptoms Improvement in Parkinson\u2019s disease through Nutritional Intervention: a Case Study","volume":"65","author":"Zanini","year":"2024","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.euros.2026.03.009_b0165","doi-asserted-by":"crossref","first-page":"e1427","DOI":"10.1212\/WNL.0000000000008931","article-title":"Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial","volume":"94","author":"McDonald","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.euros.2026.03.009_b0170","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.0b013e318219fab3","article-title":"Behavioral therapy to treat urinary incontinence in Parkinson disease","volume":"76","author":"Vaughan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.euros.2026.03.009_b0175","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/nau.24052","article-title":"Behavioral therapy for urinary symptoms in Parkinson\u2019s disease: A randomized clinical trial","volume":"38","author":"Vaughan","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euros.2026.03.009_b0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2025.1904","article-title":"Behavioral compared with drug therapy for overactive bladder symptoms in Parkinson disease: A randomized noninferiority trial","volume":"82","author":"Vaughan","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.euros.2026.03.009_b0185","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/nau.24595","article-title":"Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson\u2019s disease: a randomized clinical trial","volume":"40","author":"Araujo","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euros.2026.03.009_b0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00345-025-05597-2","article-title":"Evaluation of transcutaneous electrical tibial nerve stimulation in lower urinary tract dysfunction secondary to a parkinsonian syndrome: Uroparktens-a multicenter randomized placebo-controlled study","volume":"43","author":"Castel-Lacanal","year":"2025","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2026.03.009_b0195","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac114","article-title":"Stimulation of the tibial nerve-a randomised trial for urinary problems associated with Parkinson\u2019s-the STARTUP trial","volume":"51","author":"McClurg","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.euros.2026.03.009_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WON.0000000000000078","article-title":"Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial","volume":"42","author":"Perissinotto","year":"2015","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.euros.2026.03.009_b0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/mds.30186","article-title":"Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson\u2019s disease: results from a Phase II randomized control trial (STRIPE)","volume":"40","author":"Smith","year":"2025","journal-title":"Mov Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mds.22434","article-title":"Effects of inhibitory rTMS on bladder function in Parkinson\u2019s disease patients","volume":"24","author":"Brusa","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.parkreldis.2019.05.031","article-title":"Caloric vestibular stimulation for the management of motor and non-motor symptoms in Parkinson\u2019s disease","volume":"65","author":"Wilkinson","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.euros.2026.03.009_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107215","article-title":"A multidisciplinary telemedicine approach for managing frailty in Parkinson\u2019s disease. A longitudinal, case-control study","volume":"130","author":"Garc\u00eda-Bustillo","year":"2025","journal-title":"Parkinsonism Relat Disord"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:46:02Z","timestamp":1779306362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"alternative-id":["S2666168326000637"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.009","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Nonpharmacological and Nonsurgical Intervention for Lower Urinary Tract Symptoms in Parkinson\u2019s Disease: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}